Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12A5F | ISIN: CA31447P1009 | Ticker-Symbol: RV41
Tradegate
06.06.25 | 16:35
6,950 Euro
+0,72 % +0,050
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
FENNEC PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
FENNEC PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,0007,30017:25
7,0007,30017:19

Aktuelle News zur FENNEC PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FENNEC PHARMACEUTICALS Aktie jetzt für 0€ handeln
MiFennec Pharmaceuticals Inc: Fennec shareholders approve all matters at AGSM1
DiFennec Pharmaceuticals elects board members, shareholders approve proposals1
DiFennec Pharmaceuticals Inc.: Fennec Announces Results of Annual Meeting55RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the "Company") (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy...
► Artikel lesen
DiFENNEC PHARMACEUTICALS INC. - 8-K, Current Report1
13.05.Fennec Pharmaceuticals GAAP EPS of -$0.04 beats by $0.05, revenue of $8.75M beats by $0.57M1
13.05.Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update102~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company's Refined, Targeted Sales Strategy and Enhanced Patient Support Services...
► Artikel lesen
09.05.Fennec Pharmaceuticals Inc: Fennec to release Q1 results, host call May 132
08.05.Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 202510
26.03.FENNEC PHARMACEUTICALS INC. - 10-K, Annual Report4
11.03.Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript2
11.03.H.C. Wainwright maintains $13 target on Fennec stock3
10.03.FENNEC PHARMACEUTICALS INC. - 8-K, Current Report2
10.03.Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates2
10.03.Fennec Pharmaceuticals GAAP EPS of -$0.06, revenue of $7.93M2
10.03.Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update139~ Achieved Full-Year PEDMARK® Net Product Sales of $29.6 Million, Up 40% Year-Over-Year, and Generated PEDMARK® Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6...
► Artikel lesen
07.03.Fennec Pharmaceuticals Inc: Fennec to release 2024 results March 104
06.03.Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 20253
07.02.FENNEC PHARMACEUTICALS INC. - 8-K, Current Report-
07.02.Fennec Pharmaceuticals Inc: Fennec licensee begins selling Pedmarqsi in Germany2
07.02.Stocks in Play: Fennec Pharmaceuticals Inc.7
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1